Free Trial

Guardian Pharmacy Services (GRDN) to Release Quarterly Earnings on Monday

Guardian Pharmacy Services logo with Medical background

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data after the market closes on Monday, May 12th. Analysts expect Guardian Pharmacy Services to post earnings of $0.20 per share and revenue of $321.21 million for the quarter.

Guardian Pharmacy Services Stock Down 0.9 %

Shares of GRDN traded down $0.23 during mid-day trading on Monday, hitting $25.57. The company's stock had a trading volume of 6,454 shares, compared to its average volume of 148,087. The stock's 50-day moving average is $21.49 and its two-hundred day moving average is $21.32. Guardian Pharmacy Services has a one year low of $14.16 and a one year high of $25.98.

Analysts Set New Price Targets

Separately, Truist Financial increased their price objective on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday, April 11th.

Check Out Our Latest Report on GRDN

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines